Indian panel recommends waiving late-stage trials for some drugs

March 5, 2015 1:16 PM

8 0

MUMBAI (Reuters) - A panel of advisors to the Indian government has recommended that late-stage clinical trials be waived under certain conditions for some new drugs already being sold on international markets.

Indian law requires all medicines to be tested in late-stage clinical trials before being approved for sale. The requirements can be shortened, deferred, or omitted in certain cases, such as life-threatening diseases.

Also read: Venezuela threatens to withdraw from OAS

Read more

To category page